Escitalopram News and Updates: 2025-2026 Outlook
As of early 2024, there are no major recent news or updates specifically for escitalopram in 2025 or 2026 that have been publicly announced. Escitalopram, sold under brand names like Lexapro, is an established selective serotonin reuptake inhibitor (SSRI) used to treat depression and anxiety disorders. Its patent protection has long expired, leading to widespread generic availability.
What is Escitalopram Used For?
Escitalopram is prescribed for the treatment of major depressive disorder (MDD) in adults and adolescents 12 years of age and older. It is also used to treat generalized anxiety disorder (GAD) in adults and adolescents 12 years of age and older. The medication works by increasing the levels of serotonin, a neurotransmitter in the brain that helps regulate mood [1].
When Did Escitalopram Go Generic?
Escitalopram was first approved by the U.S. Food and Drug Administration (FDA) in 2002 [2]. The drug has been available in generic form for many years.
What Are the Side Effects of Escitalopram?
Common side effects of escitalopram can include nausea, insomnia, ejaculation disorder, fatigue, increased sweating, and decreased libido. More serious, though less common, side effects can include suicidal thoughts, serotonin syndrome, and abnormal bleeding. It is important for patients to discuss any potential side effects with their healthcare provider [1].
How Does Escitalopram Compare to Other Antidepressants?
As an SSRI, escitalopram shares a similar mechanism of action with other drugs in its class, such as sertraline (Zoloft), fluoxetine (Prozac), and citalopram (Celexa). While they share therapeutic goals, individual responses to different SSRIs can vary. Citalopram is the S-enantiomer of escitalopram, meaning escitalopram is the active isomer of citalopram [3]. Comparisons between these medications often focus on efficacy, side effect profiles, and patient tolerance.
What is the Patent Status of Escitalopram?
The original patents for escitalopram have expired. This means that multiple pharmaceutical companies manufacture and sell generic versions of the drug. DrugPatentWatch.com tracks patent information for pharmaceuticals, and escitalopram's primary patents are no longer active [4].
Who Manufactures Generic Escitalopram?
Numerous pharmaceutical manufacturers produce generic escitalopram. These companies include, but are not limited to, Teva Pharmaceuticals, Mylan, Aurobindo Pharma, and Sun Pharmaceutical Industries, among others.
What Are the Risks Associated with Escitalopram?
Escitalopram carries a boxed warning regarding the increased risk of suicidal thoughts and behaviors in children, adolescents, and young adults. Patients taking escitalopram should be closely monitored for any changes in mood or behavior. Discontinuation of escitalopram should typically be done gradually to avoid withdrawal symptoms [1].
What is the Cost of Generic Escitalopram?
The cost of generic escitalopram varies depending on the manufacturer, dosage, and pharmacy. However, as a widely available generic medication, it is generally considered affordable. Prices can range from a few dollars to around $20-$50 per prescription without insurance, depending on the source and quantity.
Sources:
[1] National Institute of Mental Health
[2] FDA Orange Book
[3] DrugBank
[4] DrugPatentWatch.com